DENALI THERAPEUTICS INC's ticker is DNLI and the CUSIP is 24823R105. A total of 208 filers reported holding DENALI THERAPEUTICS INC in Q1 2024. The put-call ratio across all filers is 0.64 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2024 | $13 | -94.1% | 578 | -94.6% | 0.01% | -94.3% |
| Q1 2024 | $220 | +42.9% | 10,744 | +50.2% | 0.14% | +33.3% |
| Q4 2023 | $154 | +2466.7% | 7,155 | +2367.2% | 0.10% | +2000.0% |
| Q3 2023 | $6 | -33.3% | 290 | -0.3% | 0.01% | -28.6% |
| Q2 2023 | $9 | +28.6% | 291 | -0.7% | 0.01% | +16.7% |
| Q1 2023 | $7 | -41.7% | 293 | -27.5% | 0.01% | +20.0% |
| Q4 2022 | $12 | -99.8% | 404 | +99.0% | 0.01% | 0.0% |
| Q3 2022 | $6,000 | – | 203 | +1461.5% | 0.01% | – |
| Q2 2022 | $0 | -100.0% | 13 | -95.0% | 0.00% | -100.0% |
| Q1 2022 | $8,000 | +14.3% | 258 | +66.5% | 0.01% | -50.0% |
| Q4 2021 | $7,000 | – | 155 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Crestline Management, LP | 7,705,039 | $343,645,000 | 25.68% |
| Casdin Capital, LLC | 1,500,000 | $66,900,000 | 1.89% |
| Flagship Pioneering Inc. | 2,619,968 | $116,851,000 | 1.81% |
| SECTORAL ASSET MANAGEMENT INC | 189,600 | $8,456,000 | 1.27% |
| Integral Health Asset Management, LLC | 100,000 | $4,460,000 | 1.23% |
| Temasek Holdings (Private) Ltd | 5,369,487 | $239,479,000 | 0.86% |
| Goldstream Capital Management Ltd | 78,418 | $3,497,000 | 0.86% |
| Yiheng Capital Management, L.P. | 335,184 | $14,949,000 | 0.76% |
| GILDER GAGNON HOWE & CO LLC | 2,900,114 | $129,345,000 | 0.74% |
| Artal Group S.A. | 600,000 | $26,760,000 | 0.73% |